Navigation Links
Bionovo, Inc. to Announce Fourth Quarter and Year-End Financial Results on Thursday, March 12, 2009
Date:3/6/2009

Company to Review Plans for 2009

EMERYVILLE, Calif., March 6 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI) announced today that it will release financial results for the fourth quarter and the year ended December 31, 2008 on Thursday, March 12, 2009. The Company will conduct a conference call and web cast to review the financial results and the Company's plans for 2009 on Thursday, March 12, 2009 at 4:30 p.m. ET.

Interested parties can access the call by dialing (877) 356-5706 or (706) 643-0580, or can listen via a live Internet web cast, which can be found at http://bionovo.com/investors/events. A replay of the call is available via web cast at http://bionovo.com/investors/events for 30 days or by playback at (800) 642-1687 or (706) 645-9291, access code 88102099, through March 15, 2009.

About Bionovo, Inc.

Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.bionovo.com. BNVI-F


'/>"/>
SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Versus Technology Announces First Quarter Results
2. Orchid Cellmark to Announce Fourth Quarter and Year-End 2008 Financial Results on March 16, 2009
3. Valeant Pharmaceuticals Announces Annual Stockholder Meeting Date
4. Gaiam to Announce Fourth Quarter 2008 and Year End Results
5. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM)
6. Stereotaxis Announces First Uses of the NAVISTAR(R) RMT THERMOCOOL(R) Catheter
7. Therapure Biopharma Inc. and LFB Biotechnologies Announce Development Services Contract for New Therapeutic Protein
8. Polymer Group, Inc. Announces Fourth Quarter and Year-End 2008 Earnings Conference Call
9. China Healthcare Acquisition Corp. Announces Stockholder Approval of Charter Amendment to Permit Early Distribution of Its Trust Fund and to Permit Its Continued Existence Without Blank Check Company Provisions and Sets Payment Date
10. Trubion Announces Dates for Fourth-Quarter and Year-Ended 2008 Earnings Conference Call
11. Karmanos Cancer Institute Announces Interim Leadership

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , ATLANTA, Dec. 2 In res...he U.S. military, FamilyLife, a non-profit ministr...will present its Weekend to Remember® marri...ry couples in Atlanta from Dec. 11 - 13 at the Gra...NE). Weekend to Remember is a marriage getaway ...
(Date:12/2/2009)..., , Ad in Today,s Washington Post H...swire-USNewswire/ -- If the Catholic bishops ha...tive measures we take for granted may be under thr...t to bear on the debate over healthcare reform has...shington Post warns of the likely impact if that ...
(Date:12/2/2009)..., , KANSAS CITY, Mo., Dec. 2 /PRN...mployers with a comprehensive, practical view on p...Congress. ,, (Logo: http://www.newscom.com/c...yers, there is good, bad, and ugly in the legislat...ttorneys in Lockton Benefit Group,s Compliance Se...
(Date:12/2/2009)...tudy finds myriad microbes in tobacco, but risk is...y News) -- New research provides evidence that th...ing bacteria that cause respiratory disease. , ... out, the authors of the new study aren,t sure wha...bacteria is nothing new: Microbes surround us ever...
(Date:12/2/2009)... Durham, NCDecember 2, 2009Ninety-six percent of l...dy on gender-based distrust indicated a strong gen...ver, this general distrust towards men did not pre...or romantic relationship. Furthermore, the union w...trusting," despite their prior assertions of distr...
Breaking Medicine News(10 mins):Health News:FamilyLife Supports Military Marriages in Atlanta 2Health News:Everybody's Healthcare Is Threatened by Catholic Bishops' Interference 2Health News:Lockton Outlines Implications of Proposed Health Reform Plans 2Health News:Smokers Inhaling Germs With Each Cigarette 2
...1Q09 Xyrem(R) net sales of $18 million are 56% hig...9 million are 50% lower than 1Q08 , , PALO ALTO, ...q: JAZZ ) today announced financial results for ... 2008. Xyrem(R) (sodium oxybate) oral solution net...
...YL, North Wales, May 7 Glan Clywd Hospital will s... more advanced radiotherapy treatments using Rapid...nt machines from Varian Medical Systems (NYSE: V...form of radiotherapy that extends more advanced ca...
...NVER, May 7 Air Methods Corporation (Nasdaq: AI... What: Air Methods Corporation Webcast, ... Where: http://www.videonewswire.com/event... to participate during the live Webcast, the call,...
...APEL HILL, N.C., May 7 When the unpredictable i...fficials warn that the seemingly lessening threat ...andemic contingency plans already, nearly one-thir... LLC primary research study on "Managing Workforce...
...affirms Full Year 2009 Revenue and Increases Low-e... , First Quarter 2009 Highlights: , , , , ...over-year and up 6.8% on a constant currency basis...of $11.2 million, up 17.2% year-over-year and up 1...
...th Annual Building Safety Week is May 3-9, 2009 ...y Week 2009, the International Code Foundation is ...o save money and prevent disasters. , , (Photo:...e water supply for granted all thanks to the enfor...
Other Medicine News:Health News:Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results 2Health News:Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results 3Health News:Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results 4Health News:Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results 5Health News:Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results 6Health News:Cancer Patients in North Wales to Gain Access to Varian's RapidArc Radiotherapy Treatments 2Health News:Corporate Pandemic Preparedness Experts from Roche & PSEG to Advise Savvy Business Leaders May 15 2Health News:Corporate Pandemic Preparedness Experts from Roche & PSEG to Advise Savvy Business Leaders May 15 3Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 2Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 3Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 4Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 5Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 6Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 7Health News:Symmetry Medical Reports First Quarter 2009 Financial Results 8Health News:Daily Dose: Safe Water News You Can Use 2Health News:Daily Dose: Safe Water News You Can Use 3
(Date:12/2/2009)... , NANJING, China, Dec. 2 /PRNewswire-As...the "Company") (NYSE: SCR ), a leading pharmaceu...ufacturing, and marketing of branded,generic and p...d that its,subsidiary Jiangsu Yanshen Biological T...suspended production of all its products in order ...
(Date:12/2/2009)... , EAST HANOVER, N.J., Dec. 2 /PRNewswir...uding a late-breaking presentation on Tasigna®... myeloid leukemia, demonstrate the strength of the...are of patients. ,, The new data, at the 51st ...g and Exposition, highlight the company,s current ...
(Date:12/1/2009)..., TEMECULA, Calif., Dec. 1 /PRNewswire-FirstCal...tin Board: PSTX) announced today that it has appoi...ef Financial Officer, Treasurer and Corporate Secr...CFO since 2008. Prior to joining Patient Safety T...ance, Chief Financial Officer, Treasurer and Corpo...
Breaking Medicine Technology:Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2Live Broadcast of Drug Rehab Graduation at Canadian Narconon 50339 1Live Broadcast of Drug Rehab Graduation at Canadian Narconon 50339 2BioSpecifics Technologies Corp Added to Russell 3000 and Russell 2000 Indexes 12832 1BioSpecifics Technologies Corp Added to Russell 3000 and Russell 2000 Indexes 12832 2Depression Anxiety Bad for the Heart 50336 1Depression Anxiety Bad for the Heart 50336 2Depression Anxiety Bad for the Heart 50336 3
OneTouch® UltraSoft® Lancets
OneTouch® Fine Point™ Lancets
Microtainer Quikheel Lancet
HEMOCHRON Jr. Signature+ Microcoagulation System
Medicine Products: